0001250853-17-000077.txt : 20170830 0001250853-17-000077.hdr.sgml : 20170830 20170830151341 ACCESSION NUMBER: 0001250853-17-000077 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170830 DATE AS OF CHANGE: 20170830 EFFECTIVENESS DATE: 20170830 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Bone Biologics Corp CENTRAL INDEX KEY: 0001419554 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 421743430 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-293771 FILM NUMBER: 171060451 BUSINESS ADDRESS: STREET 1: 2 BURLINGTON WOODS DRIVE, STREET 2: SUITE 100, CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: (781) 552-4452 MAIL ADDRESS: STREET 1: 2 BURLINGTON WOODS DRIVE, STREET 2: SUITE 100, CITY: BURLINGTON STATE: MA ZIP: 01803 FORMER COMPANY: FORMER CONFORMED NAME: Bone Biologics, Corp. DATE OF NAME CHANGE: 20140924 FORMER COMPANY: FORMER CONFORMED NAME: AFH ACQUISITION X, INC. DATE OF NAME CHANGE: 20071127 D 1 primary_doc.xml X0708 D LIVE 0001419554 Bone Biologics Corp 2 BURLINGTON WOODS DRIVE SUITE 100 BURLINGTON MA MASSACHUSETTS 01803 (781) 552-4452 DELAWARE Bone Biologics, Corp. AFH ACQUISITION X, INC. Corporation true Stephen R LaNeve 2 Burlington Woods Drive Suite 100 Burlington MA MASSACHUSETTS 01803 Executive Officer Director Chief Executive Officer Biotechnology Decline to Disclose 06b false 2017-08-18 false true true false 0 10000000 1400000 8600000 A Secured Convertible Note in the amount of $700,000 was issued to 1 investor pursuant to a Note Purchase Agreement. false 2 0 0 0 false Bone Biologics Corp /s/ Stephen R. LaNeve Stephen R. LaNeve Chief Executive Officer 2017-08-30